Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines

Go back to Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
Novavax, Inc. (NASDAQ: NVAX) Delayed: 7.96 +0.01 (0.13%)
Previous Close $7.95    52 Week High $9.23 
Open $7.91    52 Week Low $1.16 
Day High $7.99    P/E N/A 
Day Low $7.83    EPS $-0.30 
Volume 2,520,760       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.82 +0.11 (0.75%)
Previous Close $14.71    52 Week High $5.58 
Open $14.89    52 Week Low $3.60 
Day High $14.91    P/E N/A 
Day Low $14.77    EPS $0.00 
Volume 9,218,631       

SANOFI (NASDAQ: SNY) Delayed: 43.71 +0.15 (0.34%)
Previous Close $43.56    52 Week High $44.76 
Open $43.49    52 Week Low $36.81 
Day High $43.78    P/E N/A 
Day Low $43.34    EPS $0.00 
Volume 2,930,576